Insider Transactions
Date | Filer | Title | Filing | Type | Shares Traded | Price | Total Held |
---|---|---|---|---|---|---|---|
Apr 01, 2021 |
VP-Corporate Affairs
Trans History: 222
|
VP-Corporate Affairs | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 1,581 | $79.02 | 5,002 |
Apr 01, 2021 |
VP-Corporate Affairs
Trans History: 222
|
VP-Corporate Affairs | Form 4 | Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3 | 734 | $79.02 | 3,793 |
Apr 01, 2021 |
VP-Corporate Affairs
Trans History: 222
|
VP-Corporate Affairs | Form 4 | Other acquisition or disposition (describe transaction) | 759 | $79.02 | 6,583 |
Mar 31, 2023 |
Director
Trans History: 8
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 576 | $78.12 | 576 |
Mar 31, 2023 |
Director
Trans History: 26
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 576 | $78.12 | 576 |
Mar 31, 2023 |
Director
Trans History: 17
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 576 | $78.12 | 576 |
Mar 31, 2023 |
Director
Trans History: 29
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 576 | $78.12 | 576 |
Mar 31, 2023 |
Director
Trans History: 39
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 576 | $78.12 | 576 |
Mar 31, 2023 |
Director
Trans History: 2
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 576 | $78.12 | 1,134 |
Mar 31, 2023 |
Director
Trans History: 10
|
Director | Form 4 | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 576 | $78.12 | 576 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.